# Post‐Finasteride Syndrome or Pre‐Existing Vulnerability? Rethinking Patient Selection

**Authors:** Nicolò Rivetti

PMC · DOI: 10.1111/jocd.70243 · Journal of Cosmetic Dermatology · 2025-05-14

## Full-text entities

- **Diseases:** PFS (MESH:D000094025), decreased libido (MESH:D009123), anxiety (MESH:D001007), androgenetic alopecia (MESH:D000505), somatic symptom disorders (MESH:D000071896), Body Dysmorphic Disorder (MESH:D057215), fatigue (MESH:D005221), , and neuropsychiatric symptoms (MESH:D001523)
- **Chemicals:** Finasteride (MESH:D018120)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12079005/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12079005/full.md

---
Source: https://tomesphere.com/paper/PMC12079005